Literature DB >> 22074627

Cellular therapies supplement: the role of granulocyte macrophage colony-stimulating factor and dendritic cells in regulatory T-cell homeostasis and expansion.

Tao Zou1, Atsushi Satake, Priti Ojha, Taku Kambayashi.   

Abstract

Regulatory T cells are a subset of T cells with inhibitory function that are critical for protection against autoimmunity and immunopathology. A failure to maintain adequate regulatory T-cell numbers in the periphery results in autoimmune manifestations, highlighting the importance of the continuous maintenance of peripheral regulatory T cells. The cellular and molecular requirements for regulatory T-cell homeostasis and expansion are not fully understood but involve a complex interplay among dendritic cells, conventional T cells, and regulatory T cells. In addition, soluble factors such as the cytokine granulocyte macrophage colony-stimulating factor may play a role in enhancing these interactions. In this review, we discuss our National Blood Foundation-funded studies relating to the role of granulocyte macrophage colony-stimulating factor and dendritic cells in controlling regulatory T-cell homeostasis and expansion.
© 2011 American Association of Blood Banks.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22074627      PMCID: PMC4122334          DOI: 10.1111/j.1537-2995.2011.03379.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  59 in total

1.  Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide.

Authors:  M S Jordan; A Boesteanu; A J Reed; A L Petrone; A E Holenbeck; M A Lerman; A Naji; A J Caton
Journal:  Nat Immunol       Date:  2001-04       Impact factor: 25.606

2.  Homeostasis and anergy of CD4(+)CD25(+) suppressor T cells in vivo.

Authors:  Marc A Gavin; Sally R Clarke; Ella Negrou; Alena Gallegos; Alexander Rudensky
Journal:  Nat Immunol       Date:  2001-12-10       Impact factor: 25.606

3.  Control of regulatory T cell development by the transcription factor Foxp3.

Authors:  Shohei Hori; Takashi Nomura; Shimon Sakaguchi
Journal:  Science       Date:  2003-01-09       Impact factor: 47.728

Review 4.  The role of mast cells in allergy and autoimmunity.

Authors:  Michaela Robbie-Ryan; MelissaA Brown
Journal:  Curr Opin Immunol       Date:  2002-12       Impact factor: 7.486

5.  Dendritic cells induce regulatory T cell proliferation through antigen-dependent and -independent interactions.

Authors:  Tao Zou; Andrew J Caton; Gary A Koretzky; Taku Kambayashi
Journal:  J Immunol       Date:  2010-08-04       Impact factor: 5.422

6.  Peripheral expression of self-MHC-II influences the reactivity and self-tolerance of mature CD4(+) T cells: evidence from a lymphopenic T cell model.

Authors:  Avinash Bhandoola; Xuguang Tai; Michael Eckhaus; Hugh Auchincloss; Karen Mason; Steven A Rubin; Kathryn M Carbone; Zvi Grossman; Amy S Rosenberg; Alfred Singer
Journal:  Immunity       Date:  2002-10       Impact factor: 31.745

7.  Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse.

Authors:  M E Brunkow; E W Jeffery; K A Hjerrild; B Paeper; L B Clark; S A Yasayko; J E Wilkinson; D Galas; S F Ziegler; F Ramsdell
Journal:  Nat Genet       Date:  2001-01       Impact factor: 38.330

8.  Mast cells: a cellular link between autoantibodies and inflammatory arthritis.

Authors:  David M Lee; Daniel S Friend; Michael F Gurish; Christophe Benoist; Diane Mathis; Michael B Brenner
Journal:  Science       Date:  2002-09-06       Impact factor: 47.728

9.  Homeostasis of peripheral CD4+ T cells: IL-2R alpha and IL-2 shape a population of regulatory cells that controls CD4+ T cell numbers.

Authors:  Afonso R M Almeida; Nicolas Legrand; Martine Papiernik; António A Freitas
Journal:  J Immunol       Date:  2002-11-01       Impact factor: 5.422

10.  CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2.

Authors:  Thomas R Malek; Aixin Yu; Vladimir Vincek; Paul Scibelli; Lin Kong
Journal:  Immunity       Date:  2002-08       Impact factor: 31.745

View more
  8 in total

Review 1.  Bridge between neuroimmunity and traumatic brain injury.

Authors:  Matthew L Kelso; Howard E Gendelman
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

2.  Skin-derived TSLP systemically expands regulatory T cells.

Authors:  Theresa M Leichner; Atsushi Satake; Victor Sanoe Harrison; Yukinori Tanaka; Angela S Archambault; Brian S Kim; Mark C Siracusa; Warren J Leonard; Ali Naji; Gregory F Wu; David Artis; Taku Kambayashi
Journal:  J Autoimmun       Date:  2017-01-23       Impact factor: 7.094

3.  Granulocyte-macrophage colony stimulating factor exerts protective and immunomodulatory effects in cortical trauma.

Authors:  Matthew L Kelso; Bret R Elliott; Nicole A Haverland; R Lee Mosley; Howard E Gendelman
Journal:  J Neuroimmunol       Date:  2014-11-07       Impact factor: 3.478

Review 4.  The biology and therapeutic targeting of the proprotein convertases.

Authors:  Nabil G Seidah; Annik Prat
Journal:  Nat Rev Drug Discov       Date:  2012-05       Impact factor: 84.694

5.  The innate immune system stimulating cytokine GM-CSF improves learning/memory and interneuron and astrocyte brain pathology in Dp16 Down syndrome mice and improves learning/memory in wild-type mice.

Authors:  Md Mahiuddin Ahmed; Athena Ching-Jung Wang; Mihret Elos; Heidi J Chial; Stefan Sillau; D Adriana Solano; Christina Coughlan; Leila Aghili; Paige Anton; Neil Markham; Vanesa Adame; Katheleen J Gardiner; Timothy D Boyd; Huntington Potter
Journal:  Neurobiol Dis       Date:  2022-03-18       Impact factor: 7.046

6.  GM-CSF induces neuroprotective and anti-inflammatory responses in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxicated mice.

Authors:  Lisa M Kosloski; Elizabeth A Kosmacek; Katherine E Olson; R Lee Mosley; Howard E Gendelman
Journal:  J Neuroimmunol       Date:  2013-10-29       Impact factor: 3.478

7.  Inhibition of calcineurin abrogates while inhibition of mTOR promotes regulatory T cell expansion and graft-versus-host disease protection by IL-2 in allogeneic bone marrow transplantation.

Authors:  Atsushi Satake; Amanda M Schmidt; Shosaku Nomura; Taku Kambayashi
Journal:  PLoS One       Date:  2014-03-21       Impact factor: 3.240

Review 8.  Immunotherapy for Parkinson's disease.

Authors:  Aaron D Schwab; Mackenzie J Thurston; Jatin Machhi; Katherine E Olson; Krista L Namminga; Howard E Gendelman; R Lee Mosley
Journal:  Neurobiol Dis       Date:  2020-01-21       Impact factor: 5.996

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.